Search

Joseph Moore Pelham

Examiner (ID: 14289, Phone: (571)272-4786 , Office: P/3742 )

Most Active Art Unit
3742
Art Unit(s)
3761, 3742, 2106
Total Applications
2549
Issued Applications
1998
Pending Applications
99
Abandoned Applications
463

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16855227 [patent_doc_number] => 20210155972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => TARGETED RARE ALLELE CRISPR ENRICHMENT [patent_app_type] => utility [patent_app_number] => 17/102855 [patent_app_country] => US [patent_app_date] => 2020-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102855 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102855
TARGETED RARE ALLELE CRISPR ENRICHMENT Nov 23, 2020 Abandoned
Array ( [id] => 16933771 [patent_doc_number] => 20210199660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => BIOMARKERS OF BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/100106 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54924 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100106 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/100106
BIOMARKERS OF BREAST CANCER Nov 19, 2020 Abandoned
Array ( [id] => 18058429 [patent_doc_number] => 20220389515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE [patent_app_type] => utility [patent_app_number] => 17/772101 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58248 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772101 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/772101
USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE Oct 26, 2020 Abandoned
Array ( [id] => 16629019 [patent_doc_number] => 20210047672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => METHODS FOR DIAGNOSING BACTERIAL VAGINOSIS [patent_app_type] => utility [patent_app_number] => 17/079617 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079617 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/079617
Methods for diagnosing bacterial vaginosis Oct 25, 2020 Issued
Array ( [id] => 16992252 [patent_doc_number] => 20210230672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS [patent_app_type] => utility [patent_app_number] => 17/067524 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21100 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067524 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/067524
METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS Oct 8, 2020 Abandoned
Array ( [id] => 16886758 [patent_doc_number] => 20210172954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 17/035318 [patent_app_country] => US [patent_app_date] => 2020-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035318 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/035318
DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER Sep 27, 2020 Abandoned
Array ( [id] => 16720491 [patent_doc_number] => 20210087638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS [patent_app_type] => utility [patent_app_number] => 17/029684 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029684 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/029684
NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS Sep 22, 2020 Pending
Array ( [id] => 17946188 [patent_doc_number] => 20220333205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => NON-INVASIVE METHOD FOR THE DIAGNOSIS OR SCREENING OF COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF [patent_app_type] => utility [patent_app_number] => 17/625547 [patent_app_country] => US [patent_app_date] => 2020-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9034 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625547
NON-INVASIVE METHOD FOR THE DIAGNOSIS OR SCREENING OF COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF Jul 13, 2020 Pending
Array ( [id] => 17828387 [patent_doc_number] => 20220265691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES [patent_app_type] => utility [patent_app_number] => 17/626399 [patent_app_country] => US [patent_app_date] => 2020-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626399 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/626399
METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES Jul 11, 2020 Abandoned
Array ( [id] => 17913619 [patent_doc_number] => 20220316014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHODS FOR DIAGNOSING THE EFFECTIVENESS OF ANTI-TUMOR TREATMENT [patent_app_type] => utility [patent_app_number] => 17/624829 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/624829
METHODS FOR DIAGNOSING THE EFFECTIVENESS OF ANTI-TUMOR TREATMENT Jul 5, 2020 Pending
Array ( [id] => 20466826 [patent_doc_number] => 12522859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Method and kit for detecting target nucleic acid fragment [patent_app_type] => utility [patent_app_number] => 17/620868 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 34 [patent_no_of_words] => 4142 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620868 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/620868
Method and kit for detecting target nucleic acid fragment Jul 5, 2020 Issued
Array ( [id] => 16557558 [patent_doc_number] => 20210002706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => Methods For Determining Antimicrobial Drug Resistance [patent_app_type] => utility [patent_app_number] => 16/920109 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31824 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920109 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/920109
Methods For Determining Antimicrobial Drug Resistance Jul 1, 2020 Abandoned
Array ( [id] => 18170365 [patent_doc_number] => 20230036976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER [patent_app_type] => utility [patent_app_number] => 17/620573 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/620573
POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER Jun 18, 2020 Pending
Array ( [id] => 16571081 [patent_doc_number] => 20210010087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer [patent_app_type] => utility [patent_app_number] => 16/902552 [patent_app_country] => US [patent_app_date] => 2020-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902552 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/902552
Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer Jun 15, 2020 Pending
Array ( [id] => 16312738 [patent_doc_number] => 20200291476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => ASSAY FOR PRE-OPERATIVE PREDICTION OF ORGAN FUNCTION RECOVERY [patent_app_type] => utility [patent_app_number] => 16/888447 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888447 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/888447
Assay for pre-operative prediction of organ function recovery May 28, 2020 Issued
Array ( [id] => 17749993 [patent_doc_number] => 20220228198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHOD FOR MULTIPLEXED DETECTION OF NUCLEIC ACIDS USING SPECTRALLY ENCODED BEADS [patent_app_type] => utility [patent_app_number] => 17/613676 [patent_app_country] => US [patent_app_date] => 2020-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613676 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/613676
METHOD FOR MULTIPLEXED DETECTION OF NUCLEIC ACIDS USING SPECTRALLY ENCODED BEADS May 26, 2020 Pending
Array ( [id] => 16452985 [patent_doc_number] => 20200362411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => METHOD FOR PREDICTING CERVICAL SHORTENING AND PRETERM BIRTH [patent_app_type] => utility [patent_app_number] => 16/880766 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880766 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/880766
Method for predicting cervical shortening and preterm birth May 20, 2020 Issued
Array ( [id] => 16452995 [patent_doc_number] => 20200362421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER [patent_app_type] => utility [patent_app_number] => 16/863360 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863360 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/863360
CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER Apr 29, 2020 Pending
Array ( [id] => 16361450 [patent_doc_number] => 20200318201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => METHODS OF DETECTING PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 16/853027 [patent_app_country] => US [patent_app_date] => 2020-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853027 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/853027
Methods of detecting prostate cancer Apr 19, 2020 Issued
Array ( [id] => 16238678 [patent_doc_number] => 20200255912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => TET2 as a Diagnostic and Pronostic Marker in Hematopoietic Neoplasms [patent_app_type] => utility [patent_app_number] => 16/843507 [patent_app_country] => US [patent_app_date] => 2020-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843507 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/843507
TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms Apr 7, 2020 Issued
Menu